Overview

Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer

Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Metformin plus paclitaxel for recurrent or metastatic head and neck cancer: a randomized phase II trial
Phase:
Phase 2
Details
Lead Sponsor:
Lucas Vieira dos Santos
Collaborators:
Fundação de Amparo à Pesquisa do Estado de São Paulo
University of Campinas, Brazil
Treatments:
Albumin-Bound Paclitaxel
Metformin
Paclitaxel